Android app on Google Play

JPMorgan Starts Infinity Pharmaceutical (INFI) at Overweight

January 31, 2013 6:58 AM EST Send to a Friend
Get Alerts INFI Hot Sheet
Price: $10.15 --0%

Rating Summary:
    8 Buy, 7 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade INFI Now!
Join SI Premium – FREE
JPMorgan initiates coverage on Infinity Pharmaceutical (NASDAQ: INFI) with a Overweight. PT $42.00.

For an analyst ratings summary and ratings history on Infinity Pharmaceutical click here. For more ratings news on Infinity Pharmaceutical click here.

Shares of Infinity Pharmaceutical closed at $33.37 yesterday.




You May Also Be Interested In


Related Categories

New Coverage

Related Entities

JPMorgan

Add Your Comment